KYMR
Price
$33.56
Change
+$2.86 (+9.32%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.87B
7 days until earnings call
NUVL
Price
$73.98
Change
+$1.27 (+1.75%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
5.21B
14 days until earnings call
Ad is loading...

KYMR vs NUVL

Header iconKYMR vs NUVL Comparison
Open Charts KYMR vs NUVLBanner chart's image
Kymera Therapeutics
Price$33.56
Change+$2.86 (+9.32%)
Volume$21.95K
Capitalization1.87B
Nuvalent
Price$73.98
Change+$1.27 (+1.75%)
Volume$7.6K
Capitalization5.21B
KYMR vs NUVL Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. NUVL commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and NUVL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (KYMR: $30.69 vs. NUVL: $72.71)
Brand notoriety: KYMR and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 132% vs. NUVL: 64%
Market capitalization -- KYMR: $1.87B vs. NUVL: $5.21B
KYMR [@Biotechnology] is valued at $1.87B. NUVL’s [@Biotechnology] market capitalization is $5.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • NUVL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +22.66% price change this week, while NUVL (@Biotechnology) price change was +3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.21B) has a higher market cap than KYMR($1.87B). NUVL YTD gains are higher at: -7.115 vs. KYMR (-23.714). KYMR has higher annual earnings (EBITDA): -216.24M vs. NUVL (-280.37M). NUVL has more cash in the bank: 1.12B vs. KYMR (489M). KYMR has higher revenues than NUVL: KYMR (47.1M) vs NUVL (0).
KYMRNUVLKYMR / NUVL
Capitalization1.87B5.21B36%
EBITDA-216.24M-280.37M77%
Gain YTD-23.714-7.115333%
P/E RatioN/AN/A-
Revenue47.1M0-
Total Cash489M1.12B44%
Total Debt87.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
KYMRNUVL
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MAYW29.810.45
+1.55%
AllianzIM U.S. Large Cp Buffer20 May ETF
IWX77.900.64
+0.83%
iShares Russell Top 200 Value ETF
BUI22.530.16
+0.72%
BlackRock Utilities Infrastructure & Power Opportunities Trust
SNPV30.16-0.09
-0.31%
Xtrackers S&P 500 Value Scrd & Scrn ETF
SPDN11.93-0.20
-1.65%
Direxion Daily S&P 500® Bear 1X ETF

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+6.56%
CCCC - KYMR
63%
Loosely correlated
+3.21%
NRIX - KYMR
57%
Loosely correlated
+1.31%
IMNM - KYMR
55%
Loosely correlated
+3.54%
RVMD - KYMR
54%
Loosely correlated
+1.57%
RCKT - KYMR
54%
Loosely correlated
+2.44%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with ABCZF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+1.85%
ABCZF - NUVL
51%
Loosely correlated
N/A
ROIV - NUVL
47%
Loosely correlated
+2.98%
KYMR - NUVL
46%
Loosely correlated
+6.56%
RVMD - NUVL
44%
Loosely correlated
+1.57%
CRNX - NUVL
44%
Loosely correlated
+3.55%
More